Skip to main content
. 2022 May 5;12:897553. doi: 10.3389/fonc.2022.897553

Figure 2.

Figure 2

QKI downregulation in human NSCLC tissues. (A) Representative images of tumor and peritumor tissues after QKI staining. Scale bar, 200 and 50 μm (inset), respectively. (B) QKI expression was lower in tumor tissue than in ajacent non-tumor tissue (P < 0.0001). (C) KM plotter survival analysis based on microarray tissue IHC (immunohistochemistry) results containing 74 patients with NSCLC (low expression vs. high expression; HR = 2.24, 95% CI = 1.35–3.71, P = 0.007, log-rank test).